Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease

In by ECIR

Locations
Macon
Condition
Kidney Disease

Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease

  • Hidden
  • This field is for validation purposes and should be left unchanged.
clinicaltrials.gov

Eligibility

Inclusion Criteria
  1. Male or Female ≥ 18 years of age
  2. Proteinuric CKD defined as:
    • GFR 20-75 ml/min
    • UACR 200-5000 mg/g
  3. BP ≤ 150/100 mmHg
  4. BMI 18 to 45 kg/m2
Exclusion Criteria
  1. T1DM
  2. History of polycystic kidney disease or anatomical causes of CKD
  3. Treatment with simvastatin, atorvastatin, or lovastatin at doses > 40 mg/day
Back to Current Studies